Ketorolac Tromethamine Injection, Solution
Product Images NDC 51662-1702

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 51662-1702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (51662 1702 Structure)

FDA Label Image

Label (51662 1702 Table 1)

This is a detailed pharmacokinetic profile for a medication available in oral, intramuscular, and intravenous bolus administration routes. It includes information on different doses (10mg, 15mg, 30mg, 60mg), bioavailability, time parameters, and plasma concentration levels. The data provides insights into absorption, distribution, metabolism, and excretion of the drug under investigation.*

FDA Label Image

Table (51662 1702 Table 2)

FDA Label Image

Label (51662 1702 1 Vial1)

This text appears to be a mix of numeric codes and symbols that may be related to product details or manufacturer information. It includes references to a manufacturer's insert and distributor details, which suggest that the content is likely part of product packaging or labeling. The text also includes numerical sequences that appear to be product codes or identifiers.*

FDA Label Image

Label (51662 1702 2 Pouch)

This is a description of a Ketorolac Tromethamine Injection, containing 60mg per 2mL vial, with a concentration of 30mg/mL. The package details include NDC number, LOT number, and expiration date. It is for intramuscular use only and not for intravenous use. The injection includes Ketorolac Tromethamine, alcohol, sodium chloride, citric acid, and sterile water. The usual dosage information is provided in the package insert. Storage conditions are listed as 20°C to 25°C. The container closure does not contain natural rubber latex. The product is distributed by HF Acquisition and the original manufacturer's NDC is included. It is indicated for prescription-only use.*

FDA Label Image

Label (51662 1702 3 Case)

This text is a product description for Ketorolac Tromethamine Injection. It contains information such as the dosage strength, ingredients, directions for use, storage instructions, and manufacturer details. The medication is intended for intramuscular use only and is not for intravenous administration. The text also provides details on the lot number, expiration date, and National Drug Code (NDC) for the product.*

FDA Label Image

Label (63323 162 03 Ketorolac Vial Label Image 2)

This is a description of a medication called Ketorolac Tromethamine, which is an injection intended for intramuscular use only. It contains 60 mg per 2 mL (30 mg per mL) of the active ingredient. The usual dosage instructions are mentioned to be referred from the package insert. The text also mentions that it is a single-dose vial and includes the name Fresenius Kabi.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.